---
title: "Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/277988409.md"
description: "Madrigal Pharmaceuticals, Inc., based in Conshohocken, PA, disclosed on March 5, 2026, that it has granted equity awards to 20 new non-executive employees on March 1, 2026. These awards were given as equity inducement awards under Madrigal’s 2025 Inducement Plan. The granting of these equity awards was approved by Madrigal’s independent Compensation Committee in adherence to Nasdaq Listing Rule 5635(c)(4). Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is a biopharmaceutical company dedicated to developing innovative therapeutics for metabolic dysfunction-associated steatohepatitis (MASH)."
datetime: "2026-03-05T21:08:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/277988409.md)
  - [en](https://longbridge.com/en/news/277988409.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/277988409.md)
---

# Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Madrigal Pharmaceuticals, Inc., based in Conshohocken, PA, disclosed on March 5, 2026, that it has granted equity awards to 20 new non-executive employees on March 1, 2026. These awards were given as equity inducement awards under Madrigal’s 2025 Inducement Plan. The granting of these equity awards was approved by Madrigal’s independent Compensation Committee in adherence to Nasdaq Listing Rule 5635(c)(4). Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is a biopharmaceutical company dedicated to developing innovative therapeutics for metabolic dysfunction-associated steatohepatitis (MASH).

### Related Stocks

- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [MDGL.US](https://longbridge.com/en/quote/MDGL.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)

## Related News & Research

- [Gossamer Bio Receives Nasdaq Minimum Bid Price Deficiency Notice](https://longbridge.com/en/news/282247265.md)
- [BUZZ-Organon jumps on report of $12 bln buyout bid](https://longbridge.com/en/news/282320150.md)
- [Novo Nordisk's stock rallies after drugmaker reveals deal with OpenAI](https://longbridge.com/en/news/282698267.md)
- [Pancreatic cancer pill shown to nearly double overall survival time, drug company says](https://longbridge.com/en/news/282687539.md)
- [MetaVia Advances DA-1726 Obesity Trial With First Patient](https://longbridge.com/en/news/282352160.md)